Citation Impact
Citing Papers
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
2015
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
2004
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
2009
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
2006
Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
2011
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1
1996 StandoutNobel
Sarcoma and Skin Radiation Oncology
2006
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
2008
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
2015
Why not treat human cancer with interleukin-1 blockade?
2010
Cancer statistics, 2017
2017 Standout
Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis
2007
The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival
1990
New drugs in melanoma: It’s a whole new world
2011
Suppression of tumor growth through disruption of hypoxia-inducible transcription
2000 StandoutNobel
Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease
2014
Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients
2007
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
1996 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Modified Staging System for Extremity Soft Tissue Sarcomas
1999
Current and future adjuvant immunotherapies for melanoma: Blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach
2010
Melanoma Recurrence Patterns After Negative Sentinel Lymphadenectomy
2005
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Prognostic significance of autoimmunity during treatment of melanoma with interferon
2011
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk
1997
Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues
1993
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
2005 StandoutNobel
Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients
2008
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
2010 Nature
Soft-Tissue Sarcomas in Adults
2005 Standout
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma
2009
Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma
2004
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults.
1992
Lung cancer: current therapies and new targeted treatments
2016 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials
1995
Patterns of early recurrence after sentinel lymph node biopsy for melanoma
2002
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
2016
A comparison of staging systems for localized extremity soft tissue sarcoma
2000
Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas
2005
Toward the clinical application of time-domain fluorescence lifetime imaging
2005
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
2008
Lymph Node Metastasis From Soft Tissue Sarcoma in Adults Analysis of Data From a Prospective Database of 1772 Sarcoma Patients
1993
Advances in systemic treatment of melanoma
2010
A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma
2005
Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma
2011
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging
2012 StandoutNobel
Soft tissue sarcomas: Preoperative versus postoperative radiotherapy
1996
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
2009
Cancer immunotherapy comes of age
2011 StandoutNature
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Micromorphometric Features of Positive Sentinel Lymph Nodes Predict Involvement of Nonsentinel Nodes in Patients With Melanoma
2004
Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?
2003
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Randomized Clinical Trials in Soft Tissue Sarcoma
2002
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
2009
Multifactorial Analysis of Long-term Follow-up (More Than 5 Years) of Primary Extremity Sarcoma
1999
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Pathologic examination of sentinel lymph nodes from melanoma patients
2008
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Role of bacillus Calmette–Guérin in the treatment of advanced melanoma
2011
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice
2009
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence
2003
HIF and the Lung
2011 StandoutNobel
Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
2013
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
Micromorphometric Features of Positive Sentinel Lymph Nodes Predict Involvement of Nonsentinel Nodes in Patients With Melanoma
2004
Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With Melanoma
2008
Implications of Microscopic Satellites of the Primary and Extracapsular Lymph Node Spread in Patients With High-Risk Melanoma: Pathologic Corollary of Eastern Cooperative Oncology Group Trial E1690
2002
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
2011
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.
1996 Standout
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
2018 Standout
Adjuvant Therapy Of Soft-Tissue Sarcomas
1995
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
2001
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1995
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
2011
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
2003
Works of W. Ruka being referenced
Randomized Phase II Study of Docetaxel versus Doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
2000
Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KITmutations and expression
2009
Comparison between the in vitro intrinsic radiation sensitivity of human soft tissue sarcoma and breast cancer cell lines
1996
Cytokine serum levels in soft tissue sarcoma patients: Correlations with clinico‐pathological features and prognosis
2002
Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis
2003
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience
2000
Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay
2001
The effect of local recurrence on survival time in adult high-grade soft tissue sarcomas
1989
Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas
1988
Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma
2006
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1994
Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial
2005
Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes
2010
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor
2007
Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institution's experience
2003
Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
2010
Tumor size/symptom duration ratio as a prognostic factor in patients with high-grade soft tissue sarcomas
1988
Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors
2007
Fluorescence In Situ Detection of Human Cutaneous Melanoma: Study of Diagnostic Parameters of the Method
2001
Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance
2001
Clinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases.
1989
Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS)
2007
Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma
2003
Induced soft tissue sarcomas following radiation treatment for uterine carcinomas.
1991
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
2010